Many myeloproliferative neoplasms (MPNs) harbor point mutations in JAK2 (Janus kinase 2) that result in signaling hyperactivation involving signal transduction and activator of transcription factors (STATs), but constitutive PI3K/mTOR activation has also been implicated in MPNs. The gene discussed is JAK2; the disease is myeloproliferative disorder.